Position in DNLI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,283,402
-$26,556 QoQ
Shares Held
49,899
-26.9% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#116
of 290 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. DNLI ranks #51 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
17,163 | $2,278,044 | |
| 6 | CYTK |
Cytokinetics Inc
|
25,572 | $2,178,478 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
18,455 | $2,116,234 |
All Filings in DNLI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,283,402 | 49,899 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,309,958 | 68,227 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,182,677 | 71,634 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $583,065 | 40,156 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $373,854 | 26,723 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $378,879 | 27,869 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $585,619 | 28,735 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $724,113 | 24,858 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $682,041 | 29,373 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,405,086 | 68,474 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,151,865 | 53,675 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $828,377 | 40,154 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,371,477 | 46,475 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,124,974 | 48,827 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $413,451 | 14,867 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $397,803 | 12,962 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $375,997 | 12,776 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $458,551 | 14,254 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $706,464 | 15,840 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $890,593 | 17,653 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $209,513 | 2,671 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||